DK0839046T3 - TNF-receptor og steroidhormon i en kombinationsterapi - Google Patents

TNF-receptor og steroidhormon i en kombinationsterapi

Info

Publication number: DK0839046T3
Authority: DK; Denmark
Prior art keywords: tnf receptor; steroid hormone; relates; combination therapy; treatment
Prior art date: 1995-07-14

Application number

DK95926883T

Other languages

Danish (da)

English (en)

Inventor

Alessandra Boe

Francesco Borrelli

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-14

Filing date

1995-07-14

Publication date

2002-02-18

1995-07-14 Application filed by Applied Research Systems filed Critical Applied Research Systems

2002-02-18 Application granted granted Critical

2002-02-18 Publication of DK0839046T3 publication Critical patent/DK0839046T3/da

Links

108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 title abstract 2
239000003270 steroid hormone Substances 0.000 title abstract 2
102000003298 tumor necrosis factor receptor Human genes 0.000 title abstract 2
238000002648 combination therapy Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 3
108050001326 26S Proteasome regulatory subunit 6A Proteins 0.000 abstract 1
102100029510 26S proteasome regulatory subunit 6A Human genes 0.000 abstract 1
208000023275 Autoimmune disease Diseases 0.000 abstract 1
208000035143 Bacterial infection Diseases 0.000 abstract 1
206010040070 Septic Shock Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000001363 autoimmune Effects 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
231100000518 lethal Toxicity 0.000 abstract 1
230000001665 lethal effect Effects 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
230000036303 septic shock Effects 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Endocrinology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Zoology (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

DK95926883T 1995-07-14 1995-07-14 TNF-receptor og steroidhormon i en kombinationsterapi DK0839046T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP1995/002767 WO1997003686A1 (en)	1995-07-14	1995-07-14	Tnf receptor and steroid hormone in a combined therapy

Publications (1)

Publication Number	Publication Date
DK0839046T3 true DK0839046T3 (da)	2002-02-18

Family

ID=8166058

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95926883T DK0839046T3 (da)	1995-07-14	1995-07-14	TNF-receptor og steroidhormon i en kombinationsterapi

Country Status (11)

Country	Link
US (1)	US6225300B1 (de)
EP (1)	EP0839046B1 (de)
JP (1)	JP4011618B2 (de)
AT (1)	ATE212231T1 (de)
AU (1)	AU715260B2 (de)
DE (1)	DE69525181T2 (de)
DK (1)	DK0839046T3 (de)
ES (1)	ES2171547T3 (de)
IL (1)	IL118789A0 (de)
WO (1)	WO1997003686A1 (de)
ZA (1)	ZA965891B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7012060B1 (en) *	1995-07-14	2006-03-14	Applied Research Systems Ars Holding N.V.	TNF receptor and steroid hormone in a combined therapy
NL1006876C2 (nl)	1997-08-28	1999-03-02	Schiphol Luchthaven Nv	Platform voor het parkeren en afhandelen van vliegtuigen.
US6667299B1 (en) *	2000-03-16	2003-12-23	Hollis-Eden Pharmaceuticals, Inc.	Pharmaceutical compositions and treatment methods
US20040220103A1 (en)	1999-04-19	2004-11-04	Immunex Corporation	Soluble tumor necrosis factor receptor treatment of medical disorders
US20050002900A1 (en) *	2001-11-06	2005-01-06	Grace Wong	Method of treating estrogen responsive breast cancer
PT1471974E (pt) *	2002-02-06	2007-10-12	Ares Trading Sa	Factor de necrose tumural combinado com interferão em doenças desmielinizantes
JP4980048B2 (ja)	2003-02-28	2012-07-18	アレストレーディングソシエテアノニム	腫瘍壊死因子結合タンパク質の液体製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL98078A0 (en) *	1991-05-07	1992-06-21	Yeda Res & Dev	Pharmaceutical compositions comprising an anticytokyne
ATE190629T1 (de) *	1991-01-18	2000-04-15	Amgen Inc	Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten
KR100232688B1 (ko) *	1992-09-15	1999-12-01	스코트 쥐. 홀퀴스트	종양 괴사 인자 길항제를 함유하는 tnf-의존성 염증 치료용 제약 조성물
ES2153384T3 (es)	1993-07-30	2001-03-01	Kennedy Inst Of Rheumatology	Metodo para tratar la esclerosis multiple.

1995
- 1995-07-14 DK DK95926883T patent/DK0839046T3/da active
- 1995-07-14 US US08/983,223 patent/US6225300B1/en not_active Expired - Fee Related
- 1995-07-14 AU AU31109/95A patent/AU715260B2/en not_active Ceased
- 1995-07-14 DE DE69525181T patent/DE69525181T2/de not_active Expired - Fee Related
- 1995-07-14 JP JP50619297A patent/JP4011618B2/ja not_active Expired - Fee Related
- 1995-07-14 EP EP95926883A patent/EP0839046B1/de not_active Expired - Lifetime
- 1995-07-14 WO PCT/EP1995/002767 patent/WO1997003686A1/en not_active Ceased
- 1995-07-14 AT AT95926883T patent/ATE212231T1/de not_active IP Right Cessation
- 1995-07-14 ES ES95926883T patent/ES2171547T3/es not_active Expired - Lifetime
1996
- 1996-07-04 IL IL11878996A patent/IL118789A0/xx not_active IP Right Cessation
- 1996-07-11 ZA ZA965891A patent/ZA965891B/xx unknown

Also Published As

Publication number	Publication date
AU3110995A (en)	1997-02-18
EP0839046B1 (de)	2002-01-23
ZA965891B (en)	1997-03-19
AU715260B2 (en)	2000-01-20
DE69525181D1 (de)	2002-03-14
EP0839046A1 (de)	1998-05-06
US6225300B1 (en)	2001-05-01
WO1997003686A1 (en)	1997-02-06
HK1009403A1 (en)	1999-06-04
ATE212231T1 (de)	2002-02-15
ES2171547T3 (es)	2002-09-16
IL118789A0 (en)	1996-10-31
JPH11509213A (ja)	1999-08-17
JP4011618B2 (ja)	2007-11-21
DE69525181T2 (de)	2002-08-14

Publication	Publication Date	Title
EA200201000A1 (ru)	2003-02-27	Гормон-заместительная терапия
YU69000A (sh)	2003-08-29	Antitela za cd23, njihovi derivati i njihove terapeutske upotrebe
MD1920F2 (ro)	2002-05-31	Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer
EA200600964A1 (ru)	2006-10-27	Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
NZ324500A (en)	1999-08-30	Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
NO20003546L (no)	1995-06-16	Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse
ATE217192T1 (de)	2002-05-15	Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen
FR14C0051I2 (fr)	2019-01-18	Dialkylfumarates pour le traitement de maladies autoimmunes
TR199802705T2 (xx)	1999-03-22	Progestojen-anti-progestojen k�r�
DE69530308D1 (de)	2003-05-15	Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
AU3254395A (en)	1996-02-22	Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
EP0902789A4 (de)	1999-04-14
CA2454339A1 (en)	2003-02-06	Methods for preventing antipsychotic-induced weight gain
WO2006053172A3 (en)	2008-10-30	The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases
EA200301022A1 (ru)	2004-02-26	Гормональная заместительная терапия
AU2732597A (en)	1997-11-19	Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
EP0663835A1 (de)	1995-07-26	Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft.
SE9603725D0 (sv)	1996-10-11	New teatment
CA2504697A1 (en)	2004-05-21	Methods for treating migraine
DK0839046T3 (da)	2002-02-18	TNF-receptor og steroidhormon i en kombinationsterapi
AU9363398A (en)	1999-04-27	Hepatitis c receptor protein cd81
KR960030947A (ko)	1996-09-17	src SH2 특이성 화합물의 골흡수 질환 치료 용도
DK0862454T3 (da)	2002-12-30	CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DE69816808D1 (de)	2003-09-04	Somatostatin agoniste zur reduzierung von körpergewicht